Targeting Mycobacterium tuberculosis iron-scavenging tools: A recent update on siderophores inhibitors
G Kumar, PA Adhikrao - RSC Medicinal Chemistry, 2023 - pubs.rsc.org
Among the various bacterial infections, tuberculosis (TB) remains a life-threatening
infectious disease responsible as the most significant cause of mortality and morbidity …
infectious disease responsible as the most significant cause of mortality and morbidity …
Small molecules with structural similarities to siderophores as novel antimicrobials against Mycobacterium tuberculosis and Yersinia pestis
KL Stirrett, JA Ferreras, V Jayaprakash… - Bioorganic & medicinal …, 2008 - Elsevier
Drugs inhibiting the iron scarcity-induced, siderophore-mediated iron-scavenging systems of
Mycobacterium tuberculosis (Mtb) and Yersinia pestis (Yp) may provide new therapeutic …
Mycobacterium tuberculosis (Mtb) and Yersinia pestis (Yp) may provide new therapeutic …
Iron regulation in tuberculosis research: promise and challenges
Tuberculosis is a major global health challenge and is far from being controlled.
Development of resistance to currently available drugs due to the successful adaptation of …
Development of resistance to currently available drugs due to the successful adaptation of …
Iron acquisition pathways as targets for antitubercular drugs
F Meneghetti, S Villa, A Gelain… - Current Medicinal …, 2016 - ingentaconnect.com
Tuberculosis nowadays ranks as the second leading cause of death from an infectious
disease worldwide. In the last twenty years, this disease has again started to spread mainly …
disease worldwide. In the last twenty years, this disease has again started to spread mainly …
[HTML][HTML] Advances in mycobacterium siderophore-based drug discovery
J He, J Xie - Acta Pharmaceutica Sinica B, 2011 - Elsevier
Tuberculosis remains a public health threat of global proportions. Iron is a scarce resource
indispensable to both host and pathogen during infection with Mycobacterium tuberculosis …
indispensable to both host and pathogen during infection with Mycobacterium tuberculosis …
Targeting iron acquisition by Mycobacterium tuberculosis
RR Monfeli, C Beeson - Infectious Disorders-Drug Targets …, 2007 - ingentaconnect.com
Tuberculosis (TB) caused by the pathogen Mycobacterium tuberculosis continues to be a
major worldwide health problem. Lack of compliance to the complex, multi-drug therapy …
major worldwide health problem. Lack of compliance to the complex, multi-drug therapy …
Drug targeting of heme proteins in Mycobacterium tuberculosis
Highlights•Mycobacterium tuberculosis causes more deaths than any other infectious
disease.•Heme-binding enzymes are crucial for M. tuberculosis survival in its human …
disease.•Heme-binding enzymes are crucial for M. tuberculosis survival in its human …
Integrated target‐based and phenotypic screening approaches for the identification of anti‐tubercular agents that bind to the mycobacterial adenylating enzyme MbtA
Iron is essential for the pathogenicity and virulence of Mycobacterium tuberculosis, which
synthesises salicyl‐capped siderophores (mycobactins) to acquire this element from the …
synthesises salicyl‐capped siderophores (mycobactins) to acquire this element from the …
Modulating iron for metabolic support of TB host defense
Tuberculosis (TB) is the world's biggest infectious disease killer. The increasing prevalence
of multidrug-resistant and extensively drug-resistant TB demonstrates that current treatments …
of multidrug-resistant and extensively drug-resistant TB demonstrates that current treatments …
Iron Acquisition in Mycobacterium tuberculosis
The highly contagious disease tuberculosis (TB) is caused by the bacterium Mycobacterium
tuberculosis (Mtb), which has been evolving drug resistance at an alarming rate. Like all …
tuberculosis (Mtb), which has been evolving drug resistance at an alarming rate. Like all …